Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| GERON CORP | 220,000 | reported | 20 May 2026 | tx 14+1,219,627 |
| LENSAR, Inc. | 49,947 | reported | 23 May 2025 | tx 9+154,279 |
| Inhibikase Therapeutics, Inc. | 40,000 | reported | 24 Jun 2022 | tx 3+69,502 |
| SpyGlass Pharma, Inc. | 13,700 | reported | 05 Feb 2026 | tx 1+13,700 |
| PROTEIN DESIGN LABS INC/DE | 0 | reported | 23 Nov 2020 | tx 6+333,838−89,117 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2026 | GRANT_AWARD | GERON CORP | 220,000 | 0.00 USD | deriv |
| 05 Feb 2026 | GRANT_AWARD | SpyGlass Pharma, Inc. | 13,700 | 0.00 USD | deriv |
| 23 May 2025 | GRANT_AWARD | LENSAR, Inc. | 7,374 | 0.00 USD | |
| 21 May 2025 | GRANT_AWARD | GERON CORP | 180,000 | 0.00 USD | deriv |
| 09 May 2024 | GRANT_AWARD | GERON CORP | 180,000 | 0.00 USD | deriv |
| 07 May 2024 | GRANT_AWARD | LENSAR, Inc. | 22,000 | 0.00 USD | |
| 24 Aug 2023 | PURCHASE | GERON CORP | 6,607 | 2.28 USD | first after silence |
| 24 Aug 2023 | PURCHASE | GERON CORP | 6,579 | 2.28 USD | |
| 31 May 2023 | GRANT_AWARD | GERON CORP | 125,000 | 0.00 USD | deriv |
| 25 May 2023 | GRANT_AWARD | LENSAR, Inc. | 9,288 | 0.00 USD | |
| 25 May 2023 | GRANT_AWARD | LENSAR, Inc. | 33,175 | 0.00 USD | deriv |
| 24 Jun 2022 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 25 May 2022 | GRANT_AWARD | LENSAR, Inc. | 4,285 | 0.00 USD | |
| 25 May 2022 | GRANT_AWARD | LENSAR, Inc. | 15,616 | 0.00 USD | deriv |
| 10 May 2022 | GRANT_AWARD | GERON CORP | 125,000 | 0.00 USD | deriv |
| 25 Jun 2021 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 22,677 | 0.00 USD | deriv |
| 18 May 2021 | GRANT_AWARD | LENSAR, Inc. | 20,847 | 0.00 USD | deriv |
| 11 May 2021 | GRANT_AWARD | GERON CORP | 83,000 | 0.00 USD | deriv |
| 12 Mar 2021 | GRANT_AWARD | LENSAR, Inc. | 13,445 | 0.00 USD | deriv |
| 01 Feb 2021 | GRANT_AWARD | LENSAR, Inc. | 28,249 | 0.00 USD | deriv |
| 22 Dec 2020 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 6,825 | 0.00 USD | deriv |
| 23 Nov 2020 | SALE | PROTEIN DESIGN LABS INC/DE | 25,826 | 2.44 USD | |
| 18 Nov 2020 | SALE | PROTEIN DESIGN LABS INC/DE | 63,291 | 2.38 USD | |
| 21 Aug 2020 | PURCHASE | GERON CORP | 17,441 | 1.73 USD | |
| 19 Aug 2020 | GRANT_AWARD | PROTEIN DESIGN LABS INC/DE | 25,826 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 24 Aug 2023.